Note: Single-source report; awaiting corroboration.
Clinical trials at the National Institutes of Health (NIH) are essential for advancing the understanding and treatment of various illnesses. They provide valuable updates and guidance to participants and their families while generating important research data.
Alyssa, who has McCune-Albright syndrome, has participated in a longitudinal study since elementary school. Her involvement enables researchers to observe how her rare condition develops over time, benefiting both her and scientific understanding.
Annette described her experience as the mother of Lauren, a patient treated for Ewing’s sarcoma at NIH. The experience inspired her to give back by painting hospital windows in the NIH Clinical Center, showing the personal significance of clinical trials.
Caitlin, who has multiple sclerosis, decided to join a clinical trial at NIH due to worries about rapid disease progression. She hopes her participation will help develop new therapies or cures for others with MS.
David, previously diagnosed with stomach cancer, underwent surgery at NIH to remove his stomach to avoid a hereditary disease. Years later, he regained the ability to enjoy foods like hamburgers and fries, reflecting improved quality of life after treatment.
Dhruv’s experience underscores the complexities of diagnosing immune deficiencies. Initially misidentified as an allergy in India, persistent symptoms ultimately led to the discovery of Dock8 deficiency through blood testing.
Holden, a ten-year-old with Crohn’s disease, navigates the challenges of a chronic illness, setting his experiences apart from those of other children.
The NIH recognizes the invaluable contributions of clinical study participants and emphasizes that their willingness to participate is vital for medical progress and public health advances.